Literature DB >> 22806989

Sensitivity of the discrete-time Kaplan-Meier estimate to nonignorable censoring: Application in a clinical trial.

Tao Liu1, Daniel F Heitjan.   

Abstract

Untestable assumptions about the association between survival and censoring times can affect the validity of estimates of the survival distribution including the Kaplan-Meier (KM) nonparametric maximum likelihood estimate (MLE). This paper explores the sensitivity of the KM curve to nonignorable censoring by extending the index of local sensitivity to nonignorability (ISNI; Troxel et al., Statistica Sinica, 14, 1221-1237, 2004; Zhang and Heitjan, Biometrics, 62, 1260-1268, 2006) to the case of a nonparametric survival model. The method involves, first, specifying a coarse-data selection model to describe the association between the failure and censoring processes and then evaluating the slope of the nonparametric survival MLE ordinate with respect to a nonignorability parameter in the neighborhood of the ignorable model. We define the nonparametric MLE of the survival curve for a fixed value of the nonignorability parameter and show in a simulation that ISNI analysis effectively captures local sensitivity to nonignorability. The method measures sensitivity in the sense of identifying functionals of the nonparametric MLE that nonignorability, if present, can affect substantially. We demonstrate the method with an application to a trial comparing mechanical assistance to optimal medical management in the treatment of end-stage heart failure.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22806989      PMCID: PMC3876928          DOI: 10.1002/sim.5454

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  12 in total

1.  Long-term use of a left ventricular assist device for end-stage heart failure.

Authors:  E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

2.  Inference in randomized studies with informative censoring and discrete time-to-event endpoints.

Authors:  D Scharfstein; J M Robins; W Eddings; A Rotnitzky
Journal:  Biometrics       Date:  2001-06       Impact factor: 2.571

3.  A nonidentifiability aspect of the problem of competing risks.

Authors:  A Tsiatis
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

4.  Sensitivity analysis for informative censoring in parametric survival models.

Authors:  Fotios Siannis; John Copas; Guobing Lu
Journal:  Biostatistics       Date:  2005-01       Impact factor: 5.899

5.  Sensitivity analysis of causal inference in a clinical trial subject to crossover.

Authors:  Hui Xie; Daniel F Heitjan
Journal:  Clin Trials       Date:  2004-02       Impact factor: 2.486

6.  Bounds for a joint distribution function with fixed sub-distribution functions: Application to competing risks.

Authors:  A V Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

7.  A simple local sensitivity analysis tool for nonignorable coarsening: application to dependent censoring.

Authors:  Jiameng Zhang; Daniel F Heitjan
Journal:  Biometrics       Date:  2006-12       Impact factor: 2.571

8.  Nonignorable censoring in randomized clinical trials.

Authors:  Jiameng Zhang; Daniel F Heitjan
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

Review 9.  Sensitivity analysis using elicited expert information for inference with coarsened data: illustration of censored discrete event times in the AIDS Link to Intravenous Experience (ALIVE) Study.

Authors:  Michelle Shardell; Daniel O Scharfstein; David Vlahov; Noya Galai
Journal:  Am J Epidemiol       Date:  2008-10-24       Impact factor: 4.897

10.  Inference for cumulative incidence functions with informatively coarsened discrete event-time data.

Authors:  Michelle Shardell; Daniel O Scharfstein; David Vlahov; Noya Galai
Journal:  Stat Med       Date:  2008-12-10       Impact factor: 2.373

View more
  1 in total

1.  Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI).

Authors:  Manuel Montero-Odasso; Frederico Pieruccini-Faria; Robert Bartha; Sandra E Black; Elizabeth Finger; Morris Freedman; Barry Greenberg; David A Grimes; Robert A Hegele; Christopher Hudson; Peter W Kleinstiver; Anthony E Lang; Mario Masellis; Paula M McLaughlin; Douglas P Munoz; Stephen Strother; Richard H Swartz; Sean Symons; Maria Carmela Tartaglia; Lorne Zinman; Michael J Strong; William McIlroy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.